almagate has been researched along with Benign Neoplasms, Brain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanwar, JR; Kanwar, R; Sriramoju, B; Veedu, RN | 1 |
Claes, A; Hovinga, KE; Leenders, WP; Musters, GD; Peter Vandertop, W; Richel, DJ; Stalpers, LJ; van Furth, WR; Verhoeff, JJ | 1 |
1 review(s) available for almagate and Benign Neoplasms, Brain
Article | Year |
---|---|
Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
Topics: Alzheimer Disease; Aptamers, Nucleotide; Aptamers, Peptide; Blood-Brain Barrier; Brain Neoplasms; Drug Delivery Systems; Humans; Macular Degeneration; Molecular Targeted Therapy; Multiple Sclerosis; Myasthenia Gravis; Parkinson Disease; SELEX Aptamer Technique; Stroke; Theranostic Nanomedicine | 2015 |
1 other study(ies) available for almagate and Benign Neoplasms, Brain
Article | Year |
---|---|
Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma.
Topics: Angiogenesis Inhibitors; Animals; Aptamers, Nucleotide; Brain Neoplasms; Combined Modality Therapy; Disease Models, Animal; Disease-Free Survival; Female; Glioblastoma; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; Treatment Outcome; Vascular Endothelial Growth Factor A | 2009 |